Genfit S.a.
OTC: GNFTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Pascal Prigent
- Employees
- 192
- Headquarters
- Loos, France
- IPO year
- 2014
- Market cap
- $550.6M
- Website
- https://www.genfit.com
Loading GNFTF…
Loading profile data…Frequently asked questions about GNFTF
What does Genfit S.a. (GNFTF) do?
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to...
Where does GNFTF trade?
Genfit S.a. (GNFTF) trades on the Other OTC.
What sector is GNFTF in?
Genfit S.a. (GNFTF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Genfit S.a.?
Pascal Prigent is the chief executive officer of Genfit S.a. (GNFTF).
Where is Genfit S.a. headquartered?
Genfit S.a. is headquartered in France.
Does GNFTF pay a dividend?
Genfit S.a. (GNFTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GNFTF go public?
Genfit S.a. (GNFTF) completed its initial public offering in 2014.